A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Ponatinib | CAS 943319-70-8 - Request Quote

Picture of Ponatinib
SZ CAT No:SZ-P133011
CAS No
943319-70-8
Mol.F.
C29H27F3N6O
Mol.Wt.
532.6
Inv. Status
In Stock
Rel. CAT NoSZ-P133001
Rel. CAS No1114544-31-8 (HCl salt)
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Ponatinib is chemically 3-(Imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide. Ponatinib is supplied with detailed characterization data compliant with regulatory guideline. Ponatinib can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ponatinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 943319-70-8

Purchase 943319-70-8

Order 943319-70-8

Enquire 943319-70-8

price of 943319-70-8

943319-70-8 Supplier

943319-70-8 Manufacturer

943319-70-8 Exporter

buy high quality Ponatinib

Purchase Ponatinib

Ponatinib suppliers

Ponatinib manufacturers

Ponatinib price

Order Ponatinib

Enquire Ponatinib

Ponatinib cost

Ponatinib Supplier

Ponatinib Distributor

Ponatinib for Method Validation

Ponatinib Reference Standard

Ponatinib for ANDA Filing

Ponatinib for Forced Degradation Studies

Ponatinib Identification Standards

Ponatinib for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,